ROZEX

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug ROZEX contains one active pharmaceutical ingredient (API):

1 Methronidazole
UNII 140QMO216E - METRONIDAZOLE

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

Read about Methronidazole

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ROZEX Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D06BX01 Metronidazole D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BX Other chemotherapeutics
Discover more medicines within D06BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510101401166314
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 20.833-1-02-04
Country: EE Ravimiamet Identifier(s): 1012644, 1012655, 1046179, 1046180, 1046191, 1046203, 1046214, 1819234, 1829943
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60536
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 047317, 088909, 126503, 566040
Country: FR Base de données publique des médicaments Identifier(s): 60647323, 67119549, 67763113
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139633, 146681, 162359, 198608, 28405, 28406, 29236, 29238
Country: HK Department of Health Drug Office Identifier(s): 34300
Country: IE Health Products Regulatory Authority Identifier(s): 37406, 52357, 58859, 58890, 58991
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2910
Country: JP 医薬品医療機器総合機構 Identifier(s): 2699713Q1026
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1008622, 1008623, 1008624, 1008625, 1008626, 1068924, 1083923, 1086980, 1090231, 1091523
Country: MT Medicines Authority Identifier(s): MA117/00602
Country: NL Z-Index G-Standaard Identifier(s): 13832778
Country: NL Z-Index G-Standaard, PRK Identifier(s): 33480
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 5950, 5951
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100106296, 100106304, 100163035, 100258103, 100346340, 100350027, 100369771, 100394533, 100423996
Country: SG Health Sciences Authority Identifier(s): 08453P, 11198P
Country: ZA Health Products Regulatory Authority Identifier(s): 29/13.4.2/0771

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.